Deep Origin awarded $31.7M ARPA-H contract to replace animal testing with in-silico models. Learn more

Grigor Arakelov Leadership

Grigor Arakelov

Ph.D.

In Silico Drug Discovery Team Lead

Grigor Arakelov is an in silico drug discovery team lead at Deep Origin, where he applies computational biology, AI/ML, and molecular modeling to accelerate small‑molecule design. He holds a PhD in bioinformatics from the Russian‑Armenian University and has served as a senior researcher at the Institute of Molecular Biology NAS RA, as well as a lecturer at the International Scientific‑Educational Center of the NAS RA and senior lecturer at the Russian‑Armenian University. His expertise spans computational drug discovery, protein modeling, and hybrid QM/MD simulation methods for target identification and lead optimization.